Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs

Am J Physiol. 1997 Jul;273(1 Pt 1):L185-92. doi: 10.1152/ajplung.1997.273.1.L185.

Abstract

The nuclear regulatory factor (NF)-kappa B is activated in the lungs of patients with acute respiratory distress syndrome (ARDS). In experimental models of acute lung injury, activation of NF-kappa B contributes to the increased expression of immunoregulatory cytokines and other proinflammatory mediators in the lungs. Because of the important role that NF-kappa B activation appears to play in the development of acute lung injury, we examined cytoplasmic and nuclear NF-kappa B counterregulatory mechanisms in lung mononuclear cells, using a murine model in which inflammatory lung injury develops after blood loss. Sustained activation of NF-kappa B was present in lung mononuclear cells over the 4-h period after blood loss. The activation of NF-kappa B after hemorrhage was accompanied by alterations in levels of the NF-kappa B regulatory proteins I kappa B alpha and Bcl-3. Cytoplasmic and nuclear I kappa B alpha were increased and nuclear Bcl-3 was decreased during the first hour after blood loss, but, by 4 h posthemorrhage, cytoplasmic and nuclear I kappa B alpha levels were decreased and nuclear levels of Bcl-3 were increased. Inhibition of xanthine oxidase activity in otherwise unmanipulated unhemorrhaged mice resulted in increased levels of I kappa B alpha and decreased amounts of Bcl-3 in nuclear extracts from lung mononuclear cells. No changes in the levels of nuclear I kappa B alpha or Bcl-3 occurred after hemorrhage when xanthine oxidase activity was inhibited. These results demonstrate that blood loss, at least partly through xanthine oxidase-dependent mechanisms, produces alterations in the levels of both I kappa B alpha and Bcl-3 in lung mononuclear cell populations. The effects of hemorrhage on proteins that regulate activation of NF-kappa B may contribute to the frequent development of inflammatory lung injury in this setting.

MeSH terms

  • Allopurinol / pharmacology
  • Animals
  • B-Cell Lymphoma 3 Protein
  • Base Sequence
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • DNA-Binding Proteins / biosynthesis
  • Genes, Immunoglobulin
  • Hemorrhage / pathology
  • Hemorrhage / physiopathology*
  • Homeostasis
  • I-kappa B Proteins*
  • Inflammation
  • Lung / metabolism*
  • Lung / pathology
  • Lung / physiopathology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / biosynthesis*
  • NF-kappa B / genetics
  • Proto-Oncogene Proteins / biosynthesis
  • Transcription Factors

Substances

  • B-Cell Lymphoma 3 Protein
  • Bcl3 protein, mouse
  • DNA-Binding Proteins
  • I-kappa B Proteins
  • NF-kappa B
  • Nfkbia protein, mouse
  • Proto-Oncogene Proteins
  • Transcription Factors
  • NF-KappaB Inhibitor alpha
  • Allopurinol